Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001140361-22-026309
Filing Date
2022-07-19
Accepted
2022-07-19 08:01:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFC14A edge20002003x4_defc14a.htm DEFC14A 1163385
2 edge20002003x4_pc01.jpg GRAPHIC 857890
3 edge20002003x4_pc02.jpg GRAPHIC 965290
4 logo_dfkingast2.jpg GRAPHIC 30241
  Complete submission text file 0001140361-22-026309.txt   3716830
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filed by) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-51173 | Film No.: 221090419
SIC: 2834 Pharmaceutical Preparations